IBIO MEXC RealStocks
Own real IBIO shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 18:30:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
iBio, Inc. (IBIO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.79, with a market capitalization of $50.16M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.69 to $3.82. This page covers its latest market performance, valuation, price trends and company information.
$50.16M | |
$0.83 | |
$0.84 | |
$0.78 | |
$0.82 | |
165.74K | |
706.47K | |
-- | |
$3.82 | |
$0.69 | |
-- | |
-- |
iBio, Inc. (IBIO) is currently trading at $0.79 as of 2026-11-12 18:25:00, down 4.03% ($0.03) from the previous close of $0.82
During today's regular trading session, IBIO has traded between $0.78 and $0.84, with a trading volume of 165.74K shares. The current price is near the lower end of today's range.
Over the past seven days, iBio, Inc. (IBIO) moved from $0.82 to $0.79, representing a decline of 3.58% ($0.03).
The stock traded between $0.70 and $0.85 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 418.46 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 3.4%
IBIO is currently trading at $0.79, placing it 3.4% of the way from its 52-week low of $0.69 to its 52-week high of $3.82. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
iBio Inc is a clinical-stage biotechnology company using Artificial Intelligence (AI) for the development of hard-to-drug precision antibodies for obesity, cardiometabolic, and cardiopulmonary diseases. Its product candidate pipeline includes IBIO-610, a monoclonal antibody designed to block Activin E; IBIO-800, a bispecific antibody program targeting myostatin, growth differentiation factor 11 (GDF11), and Activin A; IBIO-600; Amylin Antibody; and Target 4, in different stages of development, being developed as potential therapies for obesity and cardiometabolic disease. The company operates as one reportable segment, which is that of a biotechnology company leveraging AI and ML for the development of hard-to-drug precision antibodies.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 23 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for iBio, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of iBio, Inc. (IBIO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to IBIO, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between IBIO shares and USD.
IBIO Shares to USD
1.00 IBIO shares = 0.794 USD
Calculations are estimates based on the latest available price and are for reference only.